We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 146

Apotex v. Sanofi; interlocutory motion re: affidavits of documents; clopidogrel
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

Both parties brought motions for further and better affidavits of documents


Pfizer v. Pharmascience, merits of NOC proceeding
  • Gowling Lafleur Henderson LLP
  • Canada
  • January 20 2010

The Court granted prohibition to Pfizer and found that Pharmascience’s allegations of invalidity were not justified


AstraZeneca v. Novopharm, appeal of decision to strike Statement of Claim
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes to strike AstraZeneca's Statement of Claim


Federal court affirms standing for innovative drug manufacturer
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 23 2014

What rights do innovative drug manufacturers have in situations where generics challenge certain Health Canada decisions but do not name the


PMPRB issues discussion paper on options to address the Federal Court decision in LEO Pharma
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 6 2008

The Patented Medicine Prices Review Board (PMPRB) has issued a discussion paper outlining a series of options to address the implications of the Federal Court of Canada decision in the LEO Pharma case


Data protection: defining innovative drug in Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • April 22 2013

Canada amended its Data Protection Regulations in 2006 to provide protection for innovative drugs in a second attempt to implement Canada's 1994


Recent cases
  • Gowling Lafleur Henderson LLP
  • Canada
  • August 1 2008

The Court of Appeal overturned the motions judge's decision striking the notice of appearance


AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing


Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary


Bayer v. Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register